Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat

Xue Bai1, Zhigang Bian2, Meng Zhang1

  • 1Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, 110004, Shenyang, Liaoning, PR China.

Abstract

Insights

Phytochemicals activate Nuclear factor erythroid 2-related factor 2 (Nrf2) to combat oxidative stress in neurodegenerative diseases (NDDs). These natural compounds show promise for NDD treatment, but clinical trials are needed.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular antioxidant responses.
  • Nrf2-mediated pathways are critical targets for treating neurodegenerative diseases (NDDs).
  • The therapeutic potential of phytochemicals in NDDs via Nrf2 activation requires further elucidation.

Purpose of the Study:

  • To review the therapeutic effects of phytochemicals on NDDs.
  • To examine the role of Nrf2 activation and oxidative stress reduction.
  • To assess phytochemicals as potential agents against neurodegeneration.

Main Methods:

  • Comprehensive literature search of PubMed, Google Scholar, and CNKI databases.
  • Keywords included "Nrf2", "phytochemical ingredients", "neurodegenerative diseases", and specific NDDs.
  • Analysis of 769 retrieved preclinical studies, with 39 selected for review.

Main Results:

  • Phytochemicals activate Nrf2, enhancing antioxidant defense mechanisms against NDDs.
  • Specific phytochemicals like resveratrol, curcumin, and sulforaphane show promise.
  • These compounds improve Nrf2 signaling, offering a potential therapeutic avenue.

Conclusions:

  • Phytochemicals acting as Nrf2 activators represent a novel strategy for NDD treatment.
  • Understanding the phytochemical-Nrf2 interaction provides a basis for improved NDD therapies.
  • Further clinical trials are essential to validate the safety and efficacy of these Nrf2 activators.